⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PYXS News
Pyxis Oncology, Inc. Common Stock
Form 8-K/A
sec.gov
PYXS
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
globenewswire.com
PYXS
Form 8-K
sec.gov
PYXS
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
PYXS
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
globenewswire.com
PYXS
AMGN
MRK
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
globenewswire.com
ONCY
ALLO
CHRS
PYXS
ELVN
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
globenewswire.com
PYXS
MRK
Pyxis Oncology to Participate in Upcoming Investor Conferences
globenewswire.com
PYXS
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
globenewswire.com
PYXS
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
globenewswire.com
PYXS